Related Experiment Video
Updated: May 29, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Venous thromboembolism: what to do after anticoagulation is started
Scott Kaatz1, Waqas Qureshi, Robert C Lavender
1Department of Medicine, Henry Ford Hospital, Detroit, MI 48202, USA. skaatz1@hfhs.org
For venous thromboembolism (VTE) patients on anticoagulation, key considerations include therapy duration, preventing postthrombotic syndrome, and investigating malignancy in idiopathic cases.
Area of Science:
- Hematology
- Vascular Medicine
- Oncology
Background:
- Venous thromboembolism (VTE) is a significant clinical challenge.
- Anticoagulation is the cornerstone of VTE management.
- Several post-treatment issues require careful consideration.
Purpose of the Study:
- To outline critical management aspects following anticoagulation initiation in VTE.
- To address the duration of anticoagulant therapy.
- To discuss strategies for preventing postthrombotic syndrome and the workup for malignancy in specific VTE cases.
Main Methods:
- Review of current clinical guidelines and evidence.
- Analysis of factors influencing therapeutic decisions.
- Discussion of diagnostic approaches for malignancy.
Main Results:
- Optimal anticoagulation duration varies based on VTE type and risk factors.
- Multimodal approaches are recommended for postthrombotic syndrome prevention.
- A focused malignancy workup is advised for patients with unprovoked VTE.
Conclusions:
- Comprehensive management of VTE extends beyond initial anticoagulation.
- Addressing therapy length, sequelae prevention, and underlying causes is crucial for optimal patient outcomes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
